We confirmed the therapeutic efficacy of this combination treatment using explant tissue (Figure 1H) and colonoid cultures (Figure 1I) derived from primary KRAS mutated mucinous colon/appendix cancers. The gene discussed is KRAS; the disease is appendix cancer.